15 Recommendations for Treating Glucocorticoid-Induced Osteoporosis
For the first time in seven years, the ACR has new treatment recommendations for glucocorticoid-induced osteoporosis. In this slideshow, we highlight the new guidelines.
Moderate to Severe Chronic Pain May Signal Early Death
The severity of long-term chronic pain that impedes daily life seems to be associated with higher mortality, researchers report.
Chondroitin Sulfate as Good as Celecoxib for Knee OA
Study comparing pharmaceutical-grade chondroitin sulfate to celecoxib for knee osteoarthritis shows similar rates of pain relief.
Research Roundup: Vaccine Efficacy in Rheumatoid Arthritis
Vaccine efficacy in RA, biosimilar safety and the danger of steroid injections for knee osteoarthritis top this week's research roundup. In this slideshow, we feature these and other recent research findings from the key journals.
Anti-NGF Fulranumab Effective for Pain Control in Osteoarthritis
Despite monthly dosing regimen and long half-life of fulranumab, patients experienced pain relief within a short period of time.
NSAIDs Not Always Interchangeable
Celecoxib is preferred over naproxen for arthritis patients at high risk for cardiovascular and gastrointestinal events, researchers report.
Drug Roundup: New FDA-Approved Treatments in Rheumatology
In this slideshow, we offer a glance at newly approved treatments for rheumatoid arthritis, juvenile arthritis, osteoporosis and fingernail psoriasis, among other conditions.
By clicking Accept, you agree to become a member of the UBM Medica Community.